A U.S. Justice Department (DOJ) victory in its lawsuit to block UnitedHealth Group’s (NYSE: UNH) acquisition of Amedisys (Nasdaq: AMED) is unlikely to have a cooling effect on hospice M&A, according to some experts. The UnitedHealth Group subsidiary Optum in June 2023 agreed to acquire Amedisys in a $3.3 billion deal. Optum in February 2023 […]
UnitedHealth Group
UnitedHealth Group Inc. (NYSE: UNH) is withdrawing its motion to dismiss the U.S. Department of Justice’s (DOJ) antitrust lawsuit regarding the company’s plans to acquire Amedisys in a $3.3 billion deal. UnitedHealth Group is one of the largest companies in the country and has an array of associated business lines. Should the deal go through, […]
Amedisys’ (Nasdaq: AMED) has halted the divestiture of some of its home health and hospice locations to Texas-based VitalCaring. Amedisys in June announced an agreement to sell some of its locations to the private equity-backed home health and hospice provider VitalCaring. The agreement included potentially more than 100 locations. The VitalCaring transaction was contingent on […]
UnitedHealth Group (NYSE: UNH) subsidiary Optum entered a new waiver agreement that has delayed the deadline to complete its $3.3 billion acquisition of Amedisys (Nasdaq: AMED). The agreement comes on the heels of an antitrust lawsuit that the U.S. Department of Justice (DOJ) filed last month to block the transaction due to concerns that it […]
Hospice News explores the issues garnering growing attention in end-of-life care delivery in seven of this year’s “hidden gem” stories. Topics span trends related to program integrity, workforce development, health equity, service diversification and the keys to hospices’ growth strategies. Hospice Investors to Watch Hospice merger and acquisition (M&A) activity has seen a cooling period […]
Nautic Partners and The Vistria Group, the private equity backers of home health and hospice provider Vital Caring, are mulling a potential appeal of a federal court’s recent decision in a dispute with Encompass Health (NYSE: EHC) and Enhabit Inc. (NYSE: EHAB). A federal judge in Delaware on Monday ordered VitalCaring, Nautic and Vistria to […]
The rationale behind the U.S. Justice Department’s lawsuit against Optum and Amedisys (Nasdaq: AMED) is multi-faceted, citing potential adverse impacts on competition, home-based care workers and payers. Optum, a subsidiary of UnitedHealth Group (NYSE: UNH) in June 2023 penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]
The U.S. Department of Justice (DOJ) has filed an antitrust lawsuit to block the acquisition of Amedisys (Nasdaq: AMED) by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Bloomberg first reported the news. This comes on heels of a “last rights” meeting between the DOJ and the two companies to advocate for sealing the deal. Amedisys […]
Amedisys Inc.’s (Nasdaq: AMED) hospice segment has seen headwinds impact admissions growth as the company awaits its pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. The company’s hospice segment revenue reached $207.9 million in Q3, a rise from $200.2 million during the same period last year. Gross margin for the hospice segment fell […]
Amedisys Inc. (NASDAQ: AMED) and UnitedHealth Group (NYSE: UNH) planned to meet with the U.S. Department of Justice (DOJ) this week to discuss their pending acquisition. However, DOJ has reportedly postponed any decisions until after the election. The postponement makes a DOJ lawsuit to block the deal less likely, though not impossible, before the Oct. […]